中医药治疗代谢综合征的系统评价再评价
暂无标题
- 现代中医临床 2021年28卷第2期 页码：40-46
- 作者机构：
北京中医药大学中医学院 北京 100029
- 作者简介：
#于河，女，博士，教授，硕士生导师，E-mail：yuhe221@126.com
- 基金信息：国家自然科学基金青年基金项目(No.81704121),北京中医药大学师承博士后项目(No.1000062620141)()
DOI：10.3969/j.issn.2095-6606.2021.02.009
中图分类号： R259纸质出版日期：2021-03-30，
收稿日期：2020-08-03，
- 稿件说明：
移动端阅览
崔丽军, 曹卉娟, 于河, 等. 中医药治疗代谢综合征的系统评价再评价[J]. 现代中医临床, 2021,28(2):40-46.
崔丽军, 曹卉娟, 于河, 等. 中医药治疗代谢综合征的系统评价再评价[J]. 现代中医临床, 2021,28(2):40-46. DOI： 10.3969/j.issn.2095-6606.2021.02.009.
摘要
目的
2
评价中医药干预代谢综合征系统评价的方法学质量及其结局指标的可靠程度。
方法
2
电子检索Cochrane Library、Pubmed、Web of Science，中国知网、维普、万方、中国生物医学文献数据库有关中医药治疗代谢综合征的系统评价，筛选出符合纳入标准的系统评价，检索时间为建库日至2020年3月。采用AMSTAR 2量表评价纳入研究的方法学质量，运用GRADE系统对纳入研究的结局指标进行证据质量分级。
结果
2
共纳入17个系统评价，其中进行meta分析15篇。AMSTAR 2评分均为极低质量。GRADE分级结果显示，2个结局指标的证据质量为高，8个结局指标的证据质量为中，19个结局指标的证据质量为低，60个结局指标的证据质量为极低。
结论
2
按现行评价标准显示关于代谢综合征治疗的系统评价整体方法学质量较低，结局指标可靠程度受影响，因此，临床在参考系统评价的结论时需结合临床实际情况全面考虑适用性，期待未来开展高质量的研究，为代谢综合征的临床治疗提供指导。
Abstract
Objective
2
To evaluate the quality of methodology and the reliability of its outcome indicators in systematic reviews of traditional Chinese medicine in the treatment of metabolic syndrome.
Methods
2
A few English and Chinese electronic databases including PubMed
CochraneLibrary
Web of Science
CNKI
VIP
CBM and Wanfang were retrieved electronically to screen out the systematic reviews of traditional Chinese medicine treatment for metabolic syndrome from inception to March 2020 that met the inclusion criteria. The method ological quality of the included systematic reviews was evaluated by using the AMSTAR 2 tool
and the quality of the outcome indicators of the included systematic reviews was further graded according to the GRADE system.
Results
2
A total of 17 systematic reviews were included
including 15 meta-analyses. The AMSTAR2 evaluation showed that all systematic evaluation was very low. The findings of GRADE evaluation showed that there were 2 high quality indicators
8 intermediate quality indicators
19 low-level quality indicators and 60 extremely low-level quality indicators.
Conclusions
2
The available evidence shows that the overall methodological quality of the systematic reviews for the treatment of metabolic syndrome is low
and the reliability of the outcome indicators is low. Therefore
the clinical should be cautious in using the conclusions of the systematic reviews
and high-quality research needs to be carried out in futurein order to obtain high-quality clinical evidence and provide guidelines for the treatment and management of metabolic syndrome.
关键词
中医药代谢综合征系统评价再评价AMSTAR 2量表GRADE系统
Keywords
traditional Chinese medicinemetabolic syndromeoverview of systematic reviewsAMSTAR 2 scaleGRADE system
references
ENGIN A B.The definition and prevalence of obesity and metabolic syndrome[J].Adv Exp Med Biol，2017,960:1-17.
CAMERON A J, SHAW J E, ZIMMET P Z.The metabolic syndrome: prevalence in worldwide populations[J].Endocrinology and Metabolism Clinics of North America，2004,33(2):351-375.
李宾，姜晓峰.代谢综合征的研究进展[J].国际检验医学杂志，2018,39(24):2996-3001.
ATLANTIS E, TAYLOR A W, WITTERT G, et al.Weight gain and lifestyle risk factors for developing metabolic syndrome[J].Circulation Journal: Official Journal of the Japanese Circulation Society, 2014,78(5):1066-1068.
DEFLINES J, SCHEEN A J.Management of metabolic syndrome and associated cardiovascular risk factors[J].Acta Gastroenterol Belg，2010,73(2):261-266.
祝之明.代谢综合征的临床特征与发病机制[J].第三军医大学学报，2009,31(1):17-20.
刘雅莉，袁金秋，杨克虎，等.系统评价再评价的制作方法简介及相关资料分析[J].中国循证儿科杂志，2011,6(1):58-64.
张方圆，沈傲梅，曾宪涛，等.系统评价方法学质量评价工具AMSTAR-2解读[J].中国循证心血管医学杂志，2018,10(1):14-18.
GRADE WORKING GROUP.Grading quality of evidence and strength of recommendations[J].BMJ，2004,328(7454):1490.
陈耀龙，姚亮，NORRIS S，等.GRADE在系统评价中应用的必要性及注意事项[J].中国循证医学杂志，2013,13(12):1401-1404.
朱章志.黄连温胆汤治疗代谢综合征的系统评价[C]//中国中西医结合学会.全国中西医结合内分泌代谢病学术大会暨中德代谢综合征高层论坛论文集.北京：中国中西医结合学会，2013: 412-419.
王宝，李怡.中药复方治疗老年代谢综合征Meta分析[J].北京中医药，2013,32(11):838-841.
李董平.中医治疗代谢综合征用药规律分析及Meta分析[D].广州：暨南大学，2017.
李秀敏.茶及其提取物改善代谢综合征各组分的有效性与安全性的Meta分析[D].西安：第四军医大学，2015.
郭胜童，屈娅婷，刘卜菡，等.针灸治疗代谢综合征疗效的Meta分析[J].中国中医药科技，2015,22(5):600-602.
于少丽.中医药治疗代谢综合征随机平行对照试验系统综述和Meta分析[J].实用中医内科杂志，2018,32(5):1-3.
刘艳飞，李博，刘玥，等.中药制剂对代谢综合征干预效应的Meta分析[J].医学研究杂志，2017,46(8):49-55.
朴益熙.清热健脾法治疗代谢综合征文献研究[D].北京：北京中医药大学，2015.
MOLOUD P, SHIRIN H R, NAZILA S, et al.Effect of the herbal medicines in obesity and metabolic syndrome: a systematic review and meta-analysis of clinical trials[J].Phytotherapy Research，2020,34(3):526-545.
HAMEDIFARD Z, MILAJERDIi A, REINER Z, et al.The effects of spirulina on glycemic control and serum lipoproteins in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials[J].Phytotherapy Research，2019,33(10):2609-2621.
JANG S, JANG B H, YOUME K, et al.Herbal medicines for treating metabolic syndrome: asystematic review of randomized controlled trials[J/OL].Evidence-Based Complementary and Alternative Medicine，2016[2020-05-01].https://www.hindawi.com/journals/ecam/2016/5936402/https://www.hindawi.com/journals/ecam/2016/5936402/.
ZHANG B X, YUE R S, WANG Y, et al.Effect of Hibiscus sabdariffa (Roselle) supplementation in regulating blood lipids among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis[J].Phytotherapy Research，2020,34(5):1083-1095.
AKBARI M, TAMTAJI O R, LANKARANI K B, et al.The effects of resveratrol supplementation on endothelial function and blood pressures among patients with metabolic syndrome and related disorders: asystematic review and meta-analysis of randomized controlled trials[J].High Blood Press Cardiovasc Prev，2019,26(4):305-319.
AKBARI M, LANKARANI K B, TAMTAJI O R, et al.Theeffects of curcumin on weight loss among patients with metabolic syndrome and related disorders: asystematic review and meta-analysis of randomized controlled trials[J/OL].Frontiers in Pharmacology，2019，10: 649[2020-05-01].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582779/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582779/.
OSTADMOHAMMADI V, MILAJERDI A, AYATI E, et al.Effects of quercetin supplementation on glycemic control among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials[J].Phytotherapy Research，2019,33(5):1330-1340.
TABRIZI R, VAKILI S, LANKARANI K B, et al.The effects of curcumin on glycemic control and lipid profiles among patients with metabolic syndrome and related disorders: asystematic review and meta-analysis of randomized controlled trials[J].Current Pharmaceutical Design，2018,24(27):3184-3199.
YOUSEFI R, SAIDPOUR A, MOTTAGHI A.The effects of Spirulina supplementation on metabolic syndrome components, its liver manifestation and related inflammatory markers: a systematic review[J/OL].Complementary Therapies In Medicine，2019，42: 137-144[2020-05-01].https://doi.org/10.1016/j.ctim.2018.11.013http://doi.org/10.1016/j.ctim.2018.11.013.
HOWARD B, MARK H, HOLGER JS, et al.GRADE 指南: Ⅲ.证据质量分级[J].中国循证医学杂志，2011,11(4):451-455.
熊俊，陈日新.系统评价/Meta分析方法学质量的评价工具AMSTAR[J].中国循证医学杂志，2011,11(9):1084-1089.
刘福，杨明，何梅.中文期刊发表的中医药治疗冠心病的系统评价/Meta分析的方法学质量评价[J].中国药房，2012,23(48):4546-4549.
0
浏览量
7
下载量
0
CSCD
- 网络PDF下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies